<?xml version="1.0" encoding="UTF-8"?>
<p id="Par62">Women consistently report unsafe injection behaviour in prison in the absence of accessible sterile injecting equipment [
 <xref ref-type="bibr" rid="CR13">13</xref>, 
 <xref ref-type="bibr" rid="CR78">78</xref>–
 <xref ref-type="bibr" rid="CR80">80</xref>]. This includes syringe sharing, the use of improvised injection equipment, and the use of bleach as disinfectant [
 <xref ref-type="bibr" rid="CR13">13</xref>, 
 <xref ref-type="bibr" rid="CR80">80</xref>–
 <xref ref-type="bibr" rid="CR82">82</xref>]. Women in prisons where harm reduction services are available can face the same barriers to access as women outside. Women report that stigma persists around drug use and HIV, which can discourage engagement [
 <xref ref-type="bibr" rid="CR13">13</xref>]. Finally, incarceration has a disproportionate effect on women’s access to antiretroviral therapy compared with men, due to the shorter sentences typically served by women and the challenges of continuing care between prison and the community [
 <xref ref-type="bibr" rid="CR13">13</xref>].
</p>
